DoH Prescribes MTA for Human Biological Materials
A standard Material Transfer Agreement (MTA) was published in the Government Gazette on 20 July 2018, along with a statement signed by the Minister of Health, Dr Aaron Motsoaledi, indicating that the MTA needs to be used by all providers and recipients of materials for use in research or clinical trials that are conducted under the auspices of registered Health Research Ethics Committees.
RC&I, the Office of Research Integrity and the UCT Health Research Ethics Committee have conducted a preliminary review of the standard agreement. There are some issues that require clarification, such as the inclusion of “data” in the definition of materials and currently attempting to resolve these issues with the Department of Health (DoH). UCT often receives standard MTAs from other countries (e.g. Zimbabwe) or that are used by large research consortia and how these will be accommodated needs to be established.
Depending on the outcome, the newly released UCT Materials Disclosure Forms that are required for the drafting of MTAs will be amended to meet the gazetted requirements.
Picture of Vacutainers: By Tannim101 [CC BY 3.0 (https://creativecommons.org/licenses/by/3.0), GFDL (http://www.gnu.org/copyleft/fdl.html) or CC BY 3.0 (https://creativecommons.org/licenses/by/3.0)], via Wikimedia Commons